PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28810524-11	2017	Pioglitazone treatment significantly increased urinary calcium, serum TRAP, mRNA expression of RANKL, PPAR-gamma as well as significantly decreased Runx2, OPG, osteocalcin and AMPK levels in diabetic rats.	Pioglitazone	0-12	TNF receptor superfamily member 11B	Rattus norvegicus	155-158	
23982996-10	2013	Pioglitazone reduced the ratio of RANKL to OPG, in both the serum and the inflamed synovium.	Pioglitazone	0-12	TNF receptor superfamily member 11B	Rattus norvegicus	43-46	
23982996-13	2013	CONCLUSION: Pioglitazone decreased the level of inflammatory bone destruction and protected the bone microarchitecture in rats with AIA by controlling the circulating and local expression of IL-17, with a subsequent decrease in the RANKL-to-OPG ratio.	Pioglitazone	12-24	TNF receptor superfamily member 11B	Rattus norvegicus	241-244